Internship

Intern – Applied Machine Learning for Genomic Rearrangements in Cancer

Confirmed live in the last 24 hours

Calico Labs

Calico Labs

201-500 employees

Research and develop treatments for aging

Biotechnology
Healthcare

Compensation Overview

$40 - $65Hourly

San Bruno, CA, USA

Available to work in person at our location in South San Francisco, CA during the summer months.

Category
Bioinformatics
Computational Biology
AI & Machine Learning
Biology & Biotech
Required Skills
Python
R
Requirements
  • Currently pursuing a PhD degree, in Bioinformatics, Computational Biology or related fields
  • Experience working with bioinformatic NGS processing tools and scientific programming (R/Python)
  • Knowledge of the analysis of omics data (bulk or single-cell)
  • Detail-oriented and organized
  • Strong teamwork and communication skills
  • Self-motivated with a “can-do” attitude
  • Flexible, able to respond quickly to shifting priorities and able to multitask
  • Available to work for the summer months in person at our location in South San Francisco, CA
Responsibilities
  • Adapt read alignment pipeline for ATACseq data
  • Model genomic breakpoints
  • Model impact on regulons to link the changes of gene regulatory circuitry to mutational states and differences in response to genetic perturbations from CRISPRi screens
  • Compare results to predictions from existing CNV inference methods

Calico Labs focuses on researching the biology of aging and creating treatments for age-related diseases. The company conducts scientific research to understand how aging works and the diseases that come with it. By collaborating with academic institutions and other biopharmaceutical companies, Calico Labs combines different areas of expertise to speed up research and develop new medical treatments. This partnership approach allows them to share knowledge and resources, which can lead to important discoveries in aging. They earn revenue through these collaborations, which may include joint research projects and licensing agreements for their technologies. The main goal of Calico Labs is to advance the understanding of aging and improve health outcomes for older individuals.

Company Stage

Seed

Total Funding

$2M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Calico's drug fosigotifator is in the FDA's START Pilot Program, accelerating development.
  • The company benefits from Google's $1.5B investment, boosting financial stability.
  • Calico's AI-driven drug discovery approach aligns with industry trends, enhancing innovation.

What critics are saying

  • Over-reliance on AbbVie partnership could pose risks if strategic misalignments occur.
  • Focus on rare diseases like VWM may limit market size and revenue potential.
  • Intensifying competition in anti-aging research could dilute Calico's market influence.

What makes Calico Labs unique

  • Calico Labs focuses on aging and age-related diseases, a niche in biopharmaceuticals.
  • The company leverages strategic partnerships, enhancing research and development capabilities.
  • Calico's collaboration with Broad Institute targets age-related neurodegeneration, extending until 2029.

Help us improve and share your feedback! Did you find this helpful?